Antibody-drug conjugates drug development & manufacturing trends, challenges and solutions

December 15, 2020
8:00 a.m. PST, 11:00 a.m. EST, 16:00 GMT, 17:00 CET


Antibody-drug conjugates (ADC) are complex therapeutics with multiple components, all of which require specialized teams of scientists. The field has evolved significantly over that last decade as lessons learned and novel innovations have led to increased clinical success. Yet, as more innovators join in the search for cures, competition increases as companies chase first-to-market milestones and best-in-class therapeutic status. Increasingly and to gain traction quickly, innovators look to outsource one or more aspects of production across the complex supply chain. However, the choices in outsourcing have their own challenges.
In this webinar, we will discuss ADC therapeutic market trends and technology advancements and how those trends relate and impact the selection of the optimal development and production partner.

Participants Will Learn:
  • How to simplify the ADC production supply chain
  • Value of optimizing the drug-to-antibody ratio (DAR)
  • Why experience in toxin and linker production will accelerate projects
  • Advantages of a single-source supplier

Who Should Attend:
  • Small molecule R&D scientists and manufacturing engineers
  • Large molecule R&D scientists and manufacturing engineers
  • ADC developers
  • Outsourcing / procurement managers

Brought to you by:
WuXi Biologics and STA Pharmaceutical (WuXi STA)


Ying Buechler, Ph.D.
Vice President of Development
Lily Yin
Executive Director, Head of Biologics Conjugation Development
WuXi Biologics
Youchu Wang, Ph.D.
Vice President, Process R&D
Alexandra Taylor
Associate Editor


*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy.

© 2024 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy